Mark Harvey

Hugh James is a law firm with offices throughout England and Wales. It represents clients ranging from corporations, individuals and banks to public sector organizations, property companies, educational establishments and public service providers. Hugh James’ lawyers rank high in personal injury compensation cases in independent guides such as ‘The Legal 500’ (“…the firm has enormous experience in handling complex group litigation, catastrophic injury cases and large clinical negligence disputes and is effectively the equivalent of a top London firm in the Welsh capital”) and “Chambers & Partners” (“Hugh James is one of the few firms nationwide that is at the forefront of product liability work, particularly in relation to medical devices and pharmaceuticals”). Hugh James has particular experience in cases arising from defective medical and pharmaceutical products. In addition, he regularly represents claimants in consumer and household goods matters. The firm is equally capable of assisting individual clients and providing solid support in complex group litigation.  The team often represents international plaintiffs; it has provided expert advice, but has also represented, together with advisors, successful cases in various international jurisdictions: recently, for example, it was successful in the Supreme Court of Nanterre, France, in an action brought by 1,200 British women against the company responsible for controlling the manufacturers of PIP silicone breast implants.

Hugh James has particular experience in cases arising from defective medical and pharmaceutical products. In addition, he regularly represents claimants in consumer and household goods matters. The firm is equally capable of assisting individual clients and providing solid support in complex group litigation. 

The team often represents international plaintiffs; it has provided expert advice, but has also represented, together with advisors, successful cases in various international jurisdictions: recently, for example, it was successful in the Supreme Court of Nanterre, France, in an action brought by 1,200 British women against the company responsible for controlling the manufacturers of PIP silicone breast implants.